Menstrual cyclicity post OC withdrawal in PCOS: Use of non-hormonal options

References

• Cagnacci A, Paoletti AM, Renzi A, Orru M, Pilloni M, Melis GB, et al. 2003. Glucose metabolism and insulin resistance in women with polycystic ovary syndrome during therapy with oral contraceptives containing cyproterone acetate or desogestrel. Journal of Clinical Endocrinology and Metabolism 88:3621–3625.
   PubMed Web of Science ®Google Scholar
• Cibula D, Fanta M, Hill M, Sindelka A, Skrha J, Zivny J. 2002. Insulin sensitivity in non-obese women with polycystic ovary syndrome during treatment with oral contraceptives containing low androgenic progestin. Human Reproduction 17:76–82.
   PubMed Web of Science ®Google Scholar
• Costello M, Shrestha B, Eden J, Sjoblom P, Johnson N. 2007. Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome. Cochrane Database of Systematic Reviews 22:1200–1209.
   Google Scholar
• Duijkers I, Engels L, Klipping C. 2005. Length of the menstrual cycle after discontinuation of oral contraceptives. Gynecological Endocrinology 20:74–79.
   PubMed Web of Science ®Google Scholar
• Glintborg D, Altinok ML, Mumm H, Hermann AP, Ravn P, Andersen M. 2014. Body composition is improved during 12 months' treatment with metformin alone or combined with oral contraceptives compared with treatment with oral contraceptives in polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 99:2584–2591.
   PubMed Web of Science ®Google Scholar
• Gnoth C, Frank-Herrmann P, Schmoll A, Godehardt E, Freundl G. 2002. Cycle characteristics after discontinuation of oral contraceptives. Gynecological Endocrinology16:307–317.
   PubMed Web of Science ®Google Scholar
• Hassan MA, Killick SR. 2004. Is previous use of hormonal contraception associated with a detrimental effect on subsequent fecundity? Human Reproduction 19:344–351.
   PubMed Web of Science ®Google Scholar
• Hudecova M, Holte J, Olovsson M, Larsson A, Berne C, Sundstrom-Poromaa I. 2011. Prevalence of the metabolic syndrome in women with a previous diagnosis of polycystic ovary syndrome: long-term follow-up. Fertility and Sterility 96:1271–1274.
   PubMed Web of Science ®Google Scholar
• Huggins GR, Cullins VE. 1990. Fertility after contraception or abortion. Fertility and Sterility 54:559–573.
   PubMed Web of Science ®Google Scholar
• Hull MG, Bromham DR, Savage PE, Barlow TM, Hughes AO, Jacobs HS. 1981. Post-pill amenorrhea: a causal study. Fertility and Sterility 36:472–476.
   PubMed Web of Science ®Google Scholar
• Ibanez L, de Zegher R. 2004. Ethinylestradiol-drospirenone, flutamide, metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity. Journal of Clinical Endocrinology and Metabolism 89:1592–1597.
   PubMed Web of Science ®Google Scholar
• Larsson-Cohn U. 1969. The length of the first three menstrual cycles after combined oral contraceptive treatment. Acta Obstetricia et Gynecologica Scandinavica 48:416–422.
   PubMed Web of Science ®Google Scholar
• Mastorakos G, Koliopoulos C, Creatsas G. 2002. Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives. Fertility and Sterility 77:919–927.
   PubMed Web of Science ®Google Scholar
• Morin-Papunen L, Vauhkonen I, Koivunen R, Ruokonen A, Martikainen H, Tapanainen JS. 2003. Metformin versus ethinyl/estradiol-cyproterone acetate in the treatment of non-obese women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 88:148–156.
   PubMed Web of Science ®Google Scholar
• Nader S, Diamanti-Kandarakis E. 2007. Polycystic ovary syndrome, oral contraceptives and metabolic issues: new perspectives and a unifying hypothesis. Human Reproduction 22:317–322.
   PubMed Web of Science ®Google Scholar
• Nader S, Riad-Gabriel MG, Saad MF. 2007. The effect of desogestrel-containing oral contraceptives on glucose tolerance and leptin concentrations in hyperandrogenic women. Journal of Clinical Endocrinology and Metabolism 82:3074–3077.
   Google Scholar
• Nassaralla CL, Stanford JB, Daly KD, Schneider M, Schliep KC, Fehring RJ. 2011. Characteristics of the menstrual cycle after discontinuation of oral contraceptives. Journal of Womens Health (Larchmt) 20:169–177.
   PubMed Web of Science ®Google Scholar
• Pasquali R, Gambineri A, Anconetani B, Vicennati V, Colitta D, Caramelli E, et al. 1999. The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen–progestagen treatment. Clinical Endocrinology 50:517–527.
   PubMed Web of Science ®Google Scholar
• Pasquali R, Gambineri A, Cavazza C, Ibarra Gasparini D, Ciampaglia W, Cognigni GE, et al. 2011. Heterogeneity in the responsiveness to long-term lifestyle intervention and predictability in obese women with polycystic ovary syndrome. European Journal of Endocrinology 164:53–60.
   PubMed Web of Science ®Google Scholar
• Rice-Wray E, Correu S, Gorodovsky J, Esquivel J, Goldzieher JW. 1967. Return of ovulation after discontinuance of oral contraceptives. Fertility and Sterility 18:212–218.
   PubMed Web of Science ®Google Scholar
• Steele SJ, Mason B, Brett A. 1973. Amenorrhoea after discontinuing combined oestrogen–progestogen oral contraceptives. British Medical Journal 4:343–345.
   PubMed Web of Science ®Google Scholar
• Thomas AK, Forrest MS. 1983. Menstrual pattern and fertility after treatment for anovulatory infertility. Australian and New Zealand Journal of Obstetrics and Gynaecology 23:48–50.
   PubMed Web of Science ®Google Scholar
• Troisi RJ, Cowie CC, Harris MI. 2000. Oral contraceptive use and glucose metabolism in a national sample of women in the United States. American Journal of Obstetrics and Gynaecology 183:389–395.
   PubMed Web of Science ®Google Scholar
• Somunkiran A, Yavuz T, Yucel O, Ozdemir I. 2007. Anti-Müllerian hormone levels during hormonal contraception in women with polycystic ovary syndrome. European Journal of Obstetrics and Gynaecology and Reproductive Biology 134:196–201.
   PubMed Web of Science ®Google Scholar
• Yu AF, Wu SX, Liu JL, Liu AR, Li JZ, Wu JH, et al. 1988. Metabolic changes in women using a long-acting monthly oral contraceptive and return of ovulation on discontinuation. Contraception 37:517–528.
   PubMed Web of Science ®Google Scholar